Top Markets
#1 Derive Derive +31.51%
#2 Cross Cross +16.09%
#3 Glidr Glidr +10.10%
#4 Gama Token Gama Token +9.09%
#5 Palladium Network Palladium Network +5.01%
#6 Based Based +4.88%
#7 TDCCP TDCCP +4.76%
#8 Akedo Akedo +4.66%
#9 龙虾 (Lobster) 龙虾 (Lobster) +4.64%
#10 LEO Token LEO Token +4.36%
Coin of the day
Derive Derive
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
Kedudukan dalam Saham #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
Harga Saham
$0.14966934
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$3.02M
Perubahan (1 hari)
3.72%
Perubahan (1 tahun)
-93.70%
Negara
SE
Perdagangan Guard Therapeutics International AB (publ) (GUARD)

Kategori

Healthcare
Hasil untuk Guard Therapeutics International AB (publ) (GUARD)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Guard Therapeutics International AB (publ), hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Guard Therapeutics International AB (publ) dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE